Institut für Medizininformatik, Biometrie und Epidemiologie

Intraday repeatability of macular layers measurements in glaucomatous and non-glaucomatous patients using spectral-domain optical coherence tomography (2024) Makhmutov V, Adler W, Matos PA, Kopecky A, Nemcansky J, Rokohl AC, Heindl LM Journal article What does the general population know about nonmelanoma skin cancer? Representative cross-sectional data from Germany (2024) Brokmeier L, Görig T, Spähn BA, Breitbart EW, Heppt M, Diehl K Journal article Using Heart Rate Variability to Assess Nurses’ Stress During the COVID-19 Pandemic (2024) Krieger H, Rhein C, Morawa E, Adler W, Steffan J, Lang-Richter N, Struck M, et al. Journal article Paradoxical effect of anti-inflammatory drugs on IL-6 mRNA expression in patients with PTSD during treatment (2024) Rhein C, Apelt I, Werner F, Schäflein E, Adler W, Reichel M, Schug C, et al. Journal article Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis (2024) Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau A, Li YN, Györfi AH, et al. Journal article Patients' Experience to MRI Examinations—A Systematic Qualitative Review With Meta-Synthesis (2024) Nieto Alvarez I, Madl J, Becker L, Amft O Journal article Declining frequency of sensitization to fragrance mixes I and II: IVDK-data of the years 2012-2021. (2024) Geier J, Schubert S, Rieker-Schwienbacher J, Brans R, Weisshaar E, Kränke B, Brockow K, et al. Journal article Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease. (2024) Györfi AH, Filla T, Dickel N, Möller F, Li YN, Bergmann C, Matei AE, et al. Journal article Results of patch testing with five fragrance materials hitherto not tested: A dose-finding study in the clinical population (2024) Sukakul T, Uter W, Gonçalo M, Huggard J, Ljubojević Hadžavdić S, Schuttelaar ML, Svedman C, et al. Journal article Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial. (2024) Atreya R, Kühbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al. Journal article